Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCastelnau Group Regulatory News (CGL)

Share Price Information for Castelnau Group (CGL)

Share Price is delayed by 15 minutes
Get Live Data
89.50    0.00 (0.00%)
Bid:
88.00
Ask:
91.00
Spread: 3.00 (3.409%)
Market Cap: £298.49m
CGL Live PriceLast checked at - London Stock Exchange

Intraday Castelnau Group Share Chart

Form 8.5 (EPT/RI)

11 Jan 2023 08:37

RNS Number : 3754M
Liberum Capital Limited
11 January 2023
 

 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Liberum Capital Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Castelnau Group Limited

(c) Name of the party to the offer with which exempt principal trader is connected:

Broker to Castelnau Group Limited & Dignity plc

(d) Date dealing undertaken:

10th January 2023

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

No

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

ORD NPV (Castelnau)

 

 

Purchase

 

 

30,000

 

0.73333

 

0.73333

 

ORD NPV (Castelnau)

 

 

Sale

 

 

20,000

 

0.73

 

0.73

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

Date of disclosure:

11th January 2023

 

Contact name:

Kathryn Saunders

Telephone number:

020 3100 2048

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. 

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERGIGDBSXBDGXB
Date   Source Headline
23rd Apr 202610:29 amRNS-RQ1 2026 INVESTMENT REPORT
23rd Apr 20267:00 amPRNNet Asset Value(s)
21st Apr 20267:00 amPRNAnnual Report and Audited Financial Statements 2025
12th Mar 202610:00 amPRNCOMPLETION OF SALE BY HORNBY OF SCALEXTRIC BUSINESS
27th Feb 20267:00 amPRNHORNBY AGREES SALE OF SCALEXTRIC
22nd Jan 202610:51 amRNS-RQ4 2025 INVESTMENT REPORT
22nd Jan 20269:00 amPRNNet Asset Value(s)
23rd Dec 202510:54 amRNSDirectorate change
23rd Dec 202510:54 amPRNDirectorate change
14th Nov 20252:19 pmPRNDirector/PDMR Shareholding
14th Nov 20257:30 amPRNDignity redemption and valuation update
13th Nov 20258:47 amPRNBlock Listing Six Monthly Return
23rd Oct 20259:37 amRNS-RQ3 2025 INVESTMENT REPORT
23rd Oct 20257:00 amPRNNet Asset Value(s)
18th Sep 20257:00 amPRNInterim Report and Unaudited Condensed Consolidated Interim Financial Statements
17th Sep 20253:00 pmPRNResult of Annual General Meeting
12th Sep 20257:00 amPRNCastelnau secures new debt facility
12th Aug 202511:41 amPRNNotice of AGM
24th Jul 202510:42 amRNS-RQ2 2025 INVESTMENT REPORT
9th Jul 20257:30 amPRNNet Asset Value(s)
9th Jun 20257:30 amPRNNet Asset Value(s)
2nd Jun 202510:59 amPRNTotal Voting Rights
15th May 20258:29 amPRNBlock Listing Six Monthly Return
13th May 20257:00 amPRNFurther issue of equity in relation to Hornby
9th May 20257:30 amPRNNet Asset Value(s)
1st May 20252:38 pmRNS-RQ1 2025 Investment Report
10th Apr 202511:05 amPRNAnnual Report and Audited Financial Statements 2024
8th Apr 20257:30 amPRNNet Asset Value(s)
13th Mar 20257:02 amPRNVoluntary Cancellation of Hornby plc and Issue of Shares
12th Mar 20251:43 pmPRNBlock Listing Six Monthly Return
10th Mar 20257:30 amPRNNet Asset Value(s)
10th Feb 20257:30 amPRNNet Asset Value(s)
4th Feb 20251:13 pmRNS-RQ4 2024 Quarterly Investment Report
3rd Feb 20257:00 amPRNFurther issue of equity in relation to Farewill
9th Jan 20255:17 pmPRNNet Asset Value(s)
9th Dec 20247:30 amPRNNet Asset Value(s)
8th Nov 20247:30 amPRNNet Asset Value(s)
5th Nov 20244:18 pmPRNDirector/PDMR Shareholding
17th Oct 20247:00 amPRNDignity Acquires Farewill
8th Oct 202412:59 pmPRNNet Asset Value(s)
1st Oct 20242:40 pmPRNTotal Voting Rights
26th Sep 20247:00 amPRNIona Star LP announces the successful first close of its Fund
25th Sep 20247:00 amPRNFurther issue of equity
19th Sep 20247:00 amPRNInterim Report and Unaudited Condensed Consolidated Interim Financial Statements
18th Sep 20242:12 pmPRNResult of Annual General Meeting
9th Sep 20247:30 amPRNNet Asset Value(s)
15th Aug 20248:34 amPRNNotice of AGM
8th Aug 20247:30 amPRNNet Asset Value(s)
2nd Aug 20245:06 pmPRNIssue of Shares
23rd Jul 20247:00 amPRNOcula Technologies Holdings Ltd announces successful Series A Investment round

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.